Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Assistance Publique - Hôpitaux de Paris
Patients attending to the COVID19 screening facility of Paris South University hospital and willing to participate to the study will have both nasopharyngeal and conjunctival swab for SARS-CV-2 genome detection using PCR. The project will evaluate the prevalence of positive conjunctival swabs in patients with positive nasopharyngeal swab. These results will be corelated to symptoms of disease assessed with a standardized questionnaire.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients receiving diagnostic nasopharyngeal PCR for COVID-19 as part of the usual care
Age ≥ 18.
Information and signature of consent
Affiliated with a social security scheme or entitled
You may not be if
Refusal to participate in the study
Eye surgery less than 3 months old
Unable to give informed consent
No coverage through the health insurance system
Patient under judicial protection
Patient on AME
Clareo Health | Prevalence of SARS-CoV-2 Genome in Tears of Asymptomatic and Moderately Symptomatic COVID-19 Patients
